Portfolio

Pentracor

Pentracor produces a CE approved device for the therapeutic, extracorporeal removal of CRP from blood plasma of patients with acute myocardial infarction in order to decrease long-term damage. The clinical trial provides with excellent interim results.

Info & Contact

Ahmed Sheriff
Web:
www.pentracor.de

Address

Neuendorfstraße 23 b/d
16761 Hennigsdorf

In portfolio

03. May 2011